YOU Clear Secure Inc

Dividend
1.07%
Previous close
$51.29
Est. 12 months change
+21.58%
Projected Price
$62.47

Profitability Metrics

Return on Equity (ROE)
103.64%
Return on Assets (ROA)
11.29%
Return on Invested Capital (ROIC)
35.59%
Weighted Average Cost of Capital (WACC)
10.03%
ROIC - WACC
25.56%
Updated : 2026-08-08 07:50 ET

Valuation Metrics

P/E Ratio
34.65
Forward P/E
26.72
PEG Ratio
1.31
Debt Current Ratio
1.04

Growth & Cash Flow

Gross Margin
66.66%
Operating Margin
25.13%
FCF Margin
50.80%
TTM Revenue Growth
26.56%
Projected 12M EPS Growth
29.67%

Price Change

Price % from 50 SMA
23.88%
Price % from 200 SMA
45.37%
6 Months
62.84%
1 Year
94.99%
2 Years
163.79%
Click here to see the list of ETFs containing YOU as a top holding :Clear Secure Inc ETFs

Analysis

Company Overview

Clear Secure operates the CLEAR biometric identity verification platform used at airports and sports venues, enabling expedited security screening through fingerprint and iris recognition. Sector: Technology.

Overview

Clear Secure Inc (YOU) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

From a returns-on-capital standpoint, ROIC is 35.59%, WACC is 10.03%, and the economic spread is 25.56%. On balance, the gap between ROIC and WACC places this company among the more capital-efficient baskets available. Supporting metrics show ROE at 103.64% and ROA at 11.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

The company's current market valuation reflects trailing P/E of 34.65, forward P/E of 26.72, PEG of 1.31. The trailing-to-forward compression is present but not extreme — consistent with a company where earnings are expected to grow at a steady rather than exceptional pace. On a PEG basis, the company screens as attractively priced relative to its expected earnings growth. The aggregate current ratio of 1.04 points to tighter short-term liquidity across the company. Across multiples and liquidity, the company is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

Margins & Cash Generation

On profitability at each income statement layer, gross margin sits at 66.66%, operating margin at 25.13%, and free cash flow margin at 50.80%. Gross margins are well above average, signaling strong production-level economics across the company. At this operating margin level, the the company demonstrate competent cost management and reasonable earnings durability. Free cash flow conversion is outstanding — the company is generating exceptional cash after capital expenditures. Across gross, operating, and free cash flow layers, profitability quality appears consistently strong for this company.

Growth & Forward Outlook

Looking at what the company are actually delivering versus what analysts are pricing in, TTM revenue growth of 26.56% indicating that revenue growth remains a meaningful tailwind for the company. At the same time, the estimated 12-month price change of 21.80%, where implied upside appears constructive but not aggressive. Revenue growth captures operating momentum, while price targets reflect external expectations that can move with rates, risk appetite, and sector sentiment. Whether current momentum translates into delivered returns will depend on the durability of both top-line trends and the assumptions embedded in analyst targets. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The composite of ROIC spread, valuation, revenue momentum, and analyst expectations delivers a rare alignment of quality and growth that justifies elevated conviction.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.